All posts by: Michael Zand

About Michael Zand

TechAccel partners with UC Davis to develop heat-stable wheat enzymes to improve global yield affected by climate … – BakeryAndSnacks.com

Continue reading

2018-03-20 NEWS

BakeryAndSnacks.com

TechAccel partners with UC Davis to develop heat-stable wheat enzymes to improve global yield affected by climate …
BakeryAndSnacks.com
Non-GMO wheat. “If we are successful in demonstrating the enzyme’s effectiveness, the next step will be to employ gene editing to produce a non-GMO wheat with significantly improved yield,”​ said Dr Fabbri, noting the first bags of seed would possibly

Continue reading

2018-03-20 NEWS

Oncolytics Biotech® Scientist Selected to Participate in the Society of Immunotherapy of Cancer’s (SITC) METIOR …
Marketwired (press release)
CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 20, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) ( OTCQX : ONCYF), a biotech company developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype

Continue reading

2018-03-20 NEWS

Bayer, Ginkgo Bioworks names new tech partnership Joyn Bio
AGDAILY
Joyn Bio will be digging into some of the latest advancements in synthetic biology for agriculture. Never heard of Joyn Bio? Don’t worry, until today, no one else had either. The name belongs to the new technology partnership announced between Bayer

Continue reading

2018-03-20 NEWS

Labiotech.eu (blog)

Why It’s the Best Time to Be in Cell and Gene Therapy
Labiotech.eu (blog)
Cell and gene therapies are here, and they’re here to stay. We stopped to chat about the future of the field with Alexander Vos last week at Bio Europe Spring. The cell and gene therapy space has been given a big boost in the last couple of years